Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 325 results for "cipla"

CNX IT, CNX Pharma index down 2%
Business Standard

India Pharmaceuticals and Healthcare Report Q1 2015

FEATURED COMPANIES Aurobindo Pharmaceutical Cipla Dr. Reddy's Laboratories GlaxoSmithKline Merck & Co Novartis MORE BMI View: The new government under Prime Minister Modi ... Research and Markets, 22 hours ago

91 images for cipla

Money Today, 1 day ago
Money Today, 2 days ago
NDTV Profit, 2 days ago
Times of India, 5 days ago
Financial Express, 2 days ago
MSN News, 2 days ago, 2 days ago
Money Control, 3 days ago
Money Today, 1 week ago
Bio Spectrum Asia, 1 week ago
Business Today India

Cipla V/s Novartis

The Delhi high court has reserved its verdict on a dispute between pharma firms Novartis AG and Cipla Ltd over manufacturing of the drug Indacaterol, used for treatment of chronic obstructive pulmonary disease. According to the report, the Delhi high court ...
 India Infoline2 days ago Top corporate news of the day – December 18, 2014  India Infoline2 days ago Novartis sues Cipla over drug patent, HC reserves verdict  Business Today India2 days ago HC reserves order on Novartis-Cipla drug dispute  Press Trust of India2 days ago

Novartis moves court seeking to restrain Cipla from selling respiratory drug Onbrez

MUMBAI: After the bitter patent fights on HIV, cancer and diabetes drugs between MNCs and domestic companies, the focus is now shifting to non-communicable diseases like respiratory and lung ailments. Drug MNC Novartis has moved the Delhi high court ...
 Economic Times3 days ago Novartis drags Cipla to court  Times of India3 days ago Novartis drags Cipla to court over selling of Onbrez  Economic Times3 days ago

Novartis sues Cipla for infringing patents

Comment · print · T T T+· T- TOPICS Swiss drugmaker Novartis AG said on Wednesday it had sued Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's ...
 The Hindu2 days ago

Sun Pharma, Cipla, Ranbaxy slip for second day in a row; EM currency rout may hurt

NEW DELHI: The S&P BSE Healthcare index was the one of the top sectoral index loser on the Bombay Stock Exchange, weighed down by losses in Sun Pharma, Lupin, Cipla, Aurobindo Pharma, Glenmark and Divi's Laboratories. Shares of pharma companies ...
 Economic Times3 days ago
Bio Spectrum Asia

Cipla divests its stake from a Chinese firm

Singapore: Indian pharma major, Cipla recently announced that the company's wholly owned subsidiary Meditab holdings entered into a definitive agreement to sell its entire 48.22 per cent stake in Chinese company, Jiangsu Cdymax Pharmaceuticals ...
 Bio Spectrum Asia1 week ago Cipla arm sells entire stake in Chinese firm  The Hindu1 week ago
Jagran Post

Cipla to divest holding in Chinese subsidiary Jiangsu for US$ 18.5 mn

Cipla's wholly owned subsidiary Meditab Holdings Limited, Mauritius has entered into a definitive agreement to sell its entire 48.22 per cent equity interest in Jiangsu Cdymax Pharmaceuticals Co. Ltd., China (Jiangsu) to an affiliate of one of the ...
 PharmaBiz1 week ago Cipla gains on divestment of arm's stake in Chinese firm  Business Standard1 week ago Cipla up 1.7%, subsidiary to sell stake in Chinese company  Money Control1 week ago Cipla's subsidiary sells its stake in Jiangsu Cdymax Pharmaceuticals Co., China  Capital Market1 week ago

Cipla's subsidiary Meditab sells entire stake in Jiangsu pharma for $18.5M

Mumbai-based drug maker Cipla Limited has agreed to sell its entire stake in China-based pharmaceutical company Jiangsu Cdymax Pharmaceuticals for $18.5 million, as per a stock market disclosure. The Indian drug major held 48.22 per cent stake in ...
 VC Circle1 week ago Cipla arm to sell entire stake in China's Jiangsu for $18.5 mn  Business Standard1 week ago CIPLA : To sell entire stake in china's jiangsu cdymax through meditab  4 Traders1 week ago Cipla to sell entire stake in China's Jiangsu  The Statesman1 week ago
Times of India

Government may not act on Cipla's patent plea

NEW DELHI: In a setback to Cipla, the homegrown generics medicine company, the government has so far found little merit in its plea for waiver and cancellation of patent rights for five drugs over which Novartis has exclusive rights. Sources told ...
 Times of India5 days ago Government may not act on Cipla’s patent plea  Economic Times5 days ago India: Government may not act on Cipla's patent plea  FirstWord Pharma4 days ago

Cipla gains after Meditab enters deal to sell entire stake in Jiangsu

Cipla rose 1.55% to Rs 649.75 at 15:25 IST on BSE after Meditab Holdings entered into a definitive agreement to sell its entire 48.22% equity interest in Jiangsu. The company made the announcement during market hours today, 10 December 2014. Meanwhile, the ...
 Business Standard1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cipla
Get updated on latest news & your favorite topics right in your inbox!
More     Less